Who is sponsoring NCT05550493?

NCT05550493 is sponsored by Adai Technology (Beijing) Co., Ltd..

What drugs are being tested in NCT05550493?

Interventions in NCT05550493: Cognitive Behavioral Therapy, Counseling, Approach Bias Modification, Cognitive Training.

What condition does NCT05550493 study?

NCT05550493 studies Methamphetamine Abuse.

Is NCT05550493 still recruiting?

NCT05550493 is currently completed. Last updated 2 December 2022.

Last reviewed 2022-12-02 · How we verify

NCT05550493

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Digital Therapeutics Smartphone Application for Methamphetamine Use Disorder

Completed NA Last updated 2 December 2022

What this trial tests

NA trial testing Cognitive Behavioral Therapy in Methamphetamine Abuse in 100 participants. Completed in 1 May 2022.

Timeline

1 January 2021

Primary endpoint
31 March 2021

1 May 2022

Quick facts

Lead sponsor	Adai Technology (Beijing) Co., Ltd.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	100
Start date	1 January 2021
Primary completion	31 March 2021
Estimated completion	1 May 2022
Sites	1 location across China

Drugs / interventions tested

Cognitive Behavioral Therapy
Counseling
Approach Bias Modification
Cognitive Training

Conditions studied

Methamphetamine Abuse — all drugs for Methamphetamine Abuse →

Sponsor

Adai Technology (Beijing) Co., Ltd.

Who can join

Adults 18 to 50, any sex, with Methamphetamine Abuse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

One hundred participants were recruited and randomized into a digital therapeutics (DTx) group (n=52) and a treatment as usual (TAU) group (n=48). The DTx group used a smartphone application to deliver cognitive behavioral therapy, approach bias modification, cognitive training, and contingency management for eight weeks. The TAU group received counseling from social workers and psychoterapists. Cue-induced craving, cognitive functions, PHQ-9, and GAD-7 were measured at baseline and post-intervention.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Preliminary efficacy of a digital therapeutics smartphone application for methamphetamine use disorder: An experimental study.
Zhang L, Li N, Li Y, Zhang T, et al · · 2022 · cited 8× · PMID 36339836 · DOI 10.3389/fpsyt.2022.1027695

Verify or expand the search:

Other trials of Cognitive Behavioral Therapy

Trials testing the same drug.

NCT06786429 — Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health. · Phase 4 · not yet recruiting
NCT07503951 — Cognitive Behavior Therapy in Psychiatric Inpatient Care · NA · not yet recruiting
NCT05943171 — A Randomized Controlled Trial of Digital CBT to Treat Addiction: Digital RITch®CBT vs. Standard CBT · NA · recruiting
NCT07399431 — Theta Burst Stimulation in the Management of Methamphetamine Use Disorder in Indonesia · NA · completed
NCT07432139 — Brief Emotion-Focused Therapy for Self-Criticism: A Comparison With a Cognitive-Behavioral Therapy Approach · NA · completed

Other recruiting trials for Methamphetamine Abuse

Currently open trials in the same condition.

NCT06721494 — A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamin · Phase 2 · recruiting
NCT06496750 — Ketamine for Methamphetamine Use Disorder · Phase 2 · recruiting
NCT06410196 — Mood and Decision-making in Methamphetamine Use Disorder · NA · recruiting
NCT06233799 — Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder · Phase 3 · recruiting
NCT05700994 — Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM) · NA · active not recruiting

Other Adai Technology (Beijing) Co., Ltd. trials

Trials by the same sponsor.

NCT07319325 — Efficacy of Adaptive, Gamified Digital Therapeutics Intervention for Individuals With Methamphetamine Use Disorder in Co · NA · completed
NCT06778785 — Game-Based Digital Intervention for Depression in Adolescents · NA · active not recruiting
NCT06349993 — Digital Intervention for Depression and Anxiety in Adolescents · NA · recruiting
NCT06423443 — Digital Cognitive Behavioral Therapy for Depressive Disorders · NA · recruiting
NCT06301555 — Game-Based Digital Intervention for Relieving Depression and Anxiety Symptoms · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05550493 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Adai Technology (Beijing) Co., Ltd.
Last refreshed: 2 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05550493.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing